Todd Erik Zavodnick

Todd Erik Zavodnick

Chief Executive Officer, Dermavant at Roivant Sciences Ltd.

Are you Todd Erik Zavodnick? Claim your profile
 
  • IDENTIFY executive and board member connections in Todd Erik Zavodnick's network.
  • FOLLOW changes in Todd Erik Zavodnick's employment.
  • CONNECT with Todd Erik Zavodnick through your network of contacts.

Todd Erik Zavodnick's Executive Work History


Current
Chief Executive Officer, Dermavant,
Chief Executive Officer, Dermavant
Equilar on 07/13/2022
Roivant Sciences Ltd.
Board Member,
Board Member
Equilar on 03/31/2022
Allurion Technologies, Inc.
Past
To view Todd Erik Zavodnick's complete executive work history,
Education
B.S., Rutgers University - Ernest Mario School of Pharmacy
M.B.A., University of Texas, Dallas
Age
50
 

Todd Erik Zavodnick's Biography


Todd Zavodnick has over 20 years of leadership experience in the biopharmaceutical industry. Prior to joining Dermavant in November 2018, Mr. Zavodnick served as Chief Commercial Officer and President of Aesthetics and Therapeutics at Revance. He served in global leadership roles at ZELTIQ Aesthetics prior to the company's acquisition by Allergan; at Galderma Laboratories, where he was President and General Manager of North America; and at Alcon Laboratories. He is a member of the board of directors of the Children's Skin Disease Foundation.

Source: Roivant Sciences Ltd. on 07/13/2022

 

By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Todd Erik Zavodnick. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in Todd Erik Zavodnick's network.
  • FOLLOW changes in Todd Erik Zavodnick's employment.
  • CONNECT with Todd Erik Zavodnick through your network of contacts.
 

Access over 1,500,000 executive and board member profiles.

Example: Todd Erik Zavodnick

Todd Erik Zavodnick's Connections (157)


Ram Chuttani M.D.
MD - Chief Medical Officer and Founding Partner, Allurion Technologies, Inc.
Eryn-Ashlei Bailey
Former Chief of Staff, Allurion Technologies, Inc.
Daniel Herz-Roiphe
Former Chief Operating Officer and General Counsel, Roivant Sciences Ltd.
Michael James Elliott Ph.D.
Physician-Scientist, Drug Developer, Early-Stage Life Science Investor, RI Bio
Parag V Meswani
Senior Vice President, Trofinetide – Rare Disease Franchise, ACADIA Pharmaceuticals Inc.
Eric Yuen M.D.
Board Member, Asceneuron
Xinan Chen M.D.
Executive Vice President, Huya Bioscience International, LLC
Gaston Picchio Ph.D.
Former Chief Development Officer, Arbutus Biopharma Corporation
Keith S. Manchester M.D.
Board Member, Roivant Sciences Ltd.
Sheila P. Burke
Board Member, Chubb Limited